Efficacy and safety of combination therapy with an α‐glucosidase inhibitor and a dipeptidyl peptidase‐4 inhibitor in patients with type 2 diabetes mellitus: A systematic review with meta‐analysis

AIMS/INTRODUCTION: The combination of dipeptidyl peptidase‐4 (DPP4) inhibitors and α‐glucosidase inhibitors (AGIs) might provide an additive or synergistic glucose‐lowering effect, as they have a complementary mode of action. In the present study, we examined the efficacy and safety of the addition...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Se Hee, Yoon, Jeong‐Hwa, Hahn, Seokyung, Cho, Young Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031526/
https://www.ncbi.nlm.nih.gov/pubmed/28950431
http://dx.doi.org/10.1111/jdi.12754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031526/
https://www.ncbi.nlm.nih.gov/pubmed/28950431
http://dx.doi.org/10.1111/jdi.12754

Ejemplares similares